News Search Results
Jan 08, 2026, 09:00 ET Left Lane Announces Key Partner and VP Promotions -- Reinforcing Their "Promote Within" Culture
consistency across funds, and a deeply aligned partnership culture.About Left LaneFounded in 2019, Left Lane is a global venture capital and growth equity firm investing in hyper-growth consumer and internet technology businesses with enduring customer relationships. With a lean
More news about: Left Lane Capital
Jan 08, 2026, 09:00 ET Left Lane Announces Key Partner and VP Promotions -- Reinforcing Their "Promote Within" Culture
consistency across funds, and a deeply aligned partnership culture.About Left LaneFounded in 2019, Left Lane is a global venture capital and growth equity firm investing in hyper-growth consumer and internet technology businesses with enduring customer relationships. With a lean
More news about: Left Lane Capital
Jan 08, 2026, 08:40 ET Respected Beijing Lawyer, Ning Zhu, Joins Ally Law Executive Board
markets, finance, and cross-border M&A. She has extensive professional experience in corporate listing, restructuring, private equity and venture capital, Chinese outbound investment, and arbitration. Among numerous honors, she has been recognized by IFLR1000, CBLJ, Jiemian, ALB, and the Beijing
More news about: Ally Law
Jan 08, 2026, 08:28 ET Disrupting VC Blind Spots: Chris Dolezalek on Using Data to Find the Next Unicorns
many tech pitches. "You don't have to be able to sing. You just have to look good."The "Country Club" Problem in Venture CapitalThe traditional venture capital model is increasingly disconnected from the reality of modern innovation. Decisions are frequently made based on personal
More news about: Disruption Interruption
Jan 08, 2026, 05:11 ET Ark Biopharmaceutical Receives China Marketing Authorization for Aizhida for the Treatment of ADHD
Research Institute, the Institute of Microbiology of Chinese Academy of Sciences, domestic and international biotechnology companies, as well as venture capital institutions.For more information, please visit: www.arkbiosciences.com Investor
More news about: Arkbio
Jan 08, 2026, 04:53 ET Ark Biopharmaceutical Receives China Marketing Authorization for Aizhida for the Treatment of ADHD
Research Institute, the Institute of Microbiology of Chinese Academy of Sciences, domestic and international biotechnology companies, as well as venture capital institutions.For more information, please visit: www.arkbiosciences.com Investor
More news about: Arkbio
Jan 07, 2026, 14:10 ET American Society of Gene & Cell Therapy and Orphan Therapeutics Accelerator Partner to Advance and Commercialize Promising Rare Disease Treatments
prospective investors or partners in the marketplace, thereby expanding the potential to secure funding and new clinical sponsors."Typical venture capital and biopharma expectations for returns are set well above what most CGTs for ultra-rare diseases can meet in light of recent policy and market
More news about: American Society of Gene & Cell Therapy and Orphan Therapeutics Accelerator
Jan 07, 2026, 10:25 ET Independent Wealth Management Firm, Sentinel Trust Company, LBA Announces the Promotion of Five Senior Officers
Vice President, Operations Manager; and, Ingrid Y. Tang, MBA, CFA®, CAIA to Senior Vice President, Portfolio Manager – Corporate Finance & Venture Capital. "We are incredibly pleased to announce these well-deserved promotions," remarked Lissa S. Gangjee, President and CEO of Sentinel Trust. "Their
More news about: Sentinel Trust Company, LBA
Jan 07, 2026, 09:30 ET Business Worldwide Magazine Welcome their Latest Global Corporate Excellence Award Winners
international markets, corporate finance, business strategy and changes in legislation. This readership includes CEO/CFO - Banks, Corporate Lawyers and Venture Capital/Private Equity Companies to name a few.ContactDavid Jones Awards DepartmentE:
More news about: Business Worldwide Magazine
Jan 07, 2026, 09:08 ET NOVAWAVE CAPITAL ANNOUNCES FUND MILESTONE, LAUNCHES ARIZONA COLLABORATION ON AI VENTURE STUDIO
LAS VEGAS, Jan. 7, 2026 /PRNewswire/ -- Silicon Valley–based venture capital firm NovaWave Capital announced AZ Venture Capital Inc. and Sunny Day Sports as incoming investors in the NovaWave Fund generation, further strengthening the public-private
More news about: LG Electronics USA
Jan 07, 2026, 08:34 ET The American Diabetes Association Welcomes 2026 Principal Officers and Members to the National Board of Directors
James Tai's broad life sciences and health care experience spans a wide array of outpatient provider services for chronic diseases to venture capital for life sciences companies. He sits on the board of directors for a variety of transformational health care companies that aim to improve health
More news about: American Diabetes Association
Jan 07, 2026, 08:00 ET Spiro Medical Secures $67 Million Series A Financing to Develop a Neuromodulation System for Asthma
Funds (Geneva/Boston) and Sherpa Healthcare Partners (Cayman Islands) and joined by HSG (Hong Kong), Supernova Invest (Paris), Northern Light Venture Capital (Menlo Park, CA) and Hero Inc. Ltd UK which is part of the India-based conglomerate Hero Enterprise.Proceeds from the financing will be
More news about: Spiro Medical
Jan 07, 2026, 07:33 ET Rakuten Medical Raises $100 Million in Oversubscribed Series F to Accelerate Development Toward U.S. Regulatory Approval
Life Science Fund L.P. is a venture capital fund dedicated to advancing innovative technologies in the life sciences sector. The fund was established as a joint venture between Taiwania Capital, a Taiwan national investment company, and Axil Capital, a Japanese venture capital firm supported by the Mizuho
More news about: Rakuten Medical, Inc.
Jan 07, 2026, 06:00 ET Oxford Professor Christian Rupprecht Joins Third Dimension AI as Chief Researcher
robots to autonomous vehicles—and enable new frontiers of creativity in gaming and entertainment. Third Dimension was founded in 2024 and backed by venture capital firms Felicis, Abstract, Soma Capital, MVP Ventures, and Solari Capital. To learn more, visit
More news about: Third Dimension AI, Inc
Jan 07, 2026, 04:00 ET Nucleome Therapeutics nominates first preclinical development candidate
diseases, with lead programme, NTP464, in pre-clinical development.Nucleome is backed by a world-class syndicate of investors: M Ventures, the venture capital arm of Merck KGaA; Johnson and Johnson Innovation - JJDC, Inc. ("JJDC"); Pfizer Ventures; British Business Bank and founding investor Oxford Science
More news about: Nucleome Therapeutics
Jan 07, 2026, 03:03 ET XbotPark and InnoX Power Over 40 AI Hardware Startups at CES 2026, Demonstrating Rapid Innovation at Scale
7, 2026 /PRNewswire/ -- XbotPark and InnoX Academy, a unified innovation ecosystem integrating education, incubation, manufacturing, and venture capital, return to CES 2026 with a stronger, more diverse delegation. The ecosystem exhibited over 40 pioneering AI hardware startups spanning lifestyle,
More news about: XbotPark
Jan 06, 2026, 16:30 ET CRH Ventures partners with Citylogix to accelerate digital transformation in road infrastructure management
NEW YORK, Jan. 6, 2026 /PRNewswire/ -- CRH Ventures, the venture capital unit of CRH, today announced a strategic investment in Citylogix, a North American leader in AI-powered pavement condition assessments and enterprise
More news about: CRH Ventures
Jan 06, 2026, 12:33 ET Leen Kawas Welcomes Life Sciences Executive Laurie Heilmann to Propel Bio Partners as Venture Partner to Strengthen Strategic Leadership
meaningfully improve lives," said Laurie Heilmann.About Propel Bio PartnersPropel Bio Partners is a Los Angeles-based venture capital firm focused on healthcare and life sciences investments. Co-founded in 2022 by Dr. Leen Kawas and Richard Kayne, the firm combines financial investment
More news about: Propel Bio Partners
Jan 06, 2026, 11:02 ET Merchant & Gould Opens Boston Office, Strengthening Its Depth and Breadth
life sciences and advanced technology and our 125-year history of protecting innovation are well suited to the area's technology, research, and venture capital communities," said Heather Kliebenstein, Merchant's Managing Partner. "Merchant's presence in Boston enables closer collaboration with innovators
More news about: Merchant & Gould
Jan 06, 2026, 09:00 ET HighVista Strategies Appoints Three Senior Leaders as Partners
high conviction. HighVista's capabilities span private markets, including private credit, lower middle market private equity, and early-stage venture capital; public markets, including biotechnology equities and hedged public markets strategies; as well as multi-asset alternatives.Media Contacts
More news about: HighVista Strategies LLC
Jan 06, 2026, 08:30 ET ePlus Appoints Mike Portegello to Board of Directors
He carries a Bachelor of Science in Accounting from St. John's University. He recently completed Columbia Business School Executive Education's Venture Capital Private Equity and Corporate Governance Programs.About ePlus inc.ePlus is a customer-first, services-led, and results-driven
More news about: EPLUS INC.
Jan 06, 2026, 08:01 ET Lupus Research Alliance Launches New Philanthropic Fund to Advance Treatments and Diagnostics
will serve as the Fund's inaugural Managing Director. Mr. Rastogi is an accomplished life sciences investor with more than a decade of biotech venture capital and private equity experience. He has served as a Board Director and operating partner for multiple biotech and medtech companies throughout his
More news about: Lupus Research Alliance
Jan 06, 2026, 07:00 ET GigaStar Appoints Ex-Songfinch Founder & Media Entrepreneur Scott Kitun as Chief Business Officer
on the Inc. 5000 list in 2023, as it surpassed $100M in lifetime sales and paid ~$50M to artists, and raised capital from titans of music and venture capital, including the late Quincy Jones, The Weeknd, Doja Cat, Goodwater Capital, Corazon, and Valor Equity."GigaStar is a unique opportunity for
More news about: GigaStar
Jan 06, 2026, 04:06 ET Grojet Puts Kirana Stores Back at the Heart of India's Retail Future
IndiaThe Indian retail landscape is at a crossroads. The industry is beginning to question the long-term viability of ultra-fast deliveries funded by venture capital. Grojet's approach suggests that the future isn't about choosing between technology and tradition—it's about merging them."Convenience is
More news about: Grojet
Jan 05, 2026, 13:38 ET Shipman Elevates Talent, Promotes Two Attorneys to Partnership
Group, where he represents a variety of companies and venture capital funds on a wide range of corporate and transactional matters. He advises clients at all stages of growth in mergers and acquisitions, company formation, seed and venture capital financing, and serves as outside general counsel in connection
More news about: Shipman & Goodwin, LLP